New Breast Cancer Findings from Genentech Described [A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic ...]

Source :: Biotech Week. September 13, 2017, 166
Publication Year :: 2017
Abstract: 2017 SEP 13 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Investigators publish new report on Oncology - Breast Cancer. According to news reporting from San [...]

Subjects :: Care and treatment
Research
Reports
Cancer research -- Reports
Epidermal growth factors -- Reports
Cancer patients -- Care and treatment -- Reports
Breast cancer -- Research -- Care and treatment -- Reports
Trastuzumab -- Research -- Reports
Cancer metastasis -- Research -- Care and treatment -- Reports
Biological products industry -- Reports

Tools